Latest News

Today the Life Sciences research arm of a Japanese conglomerate has appointed Aagami as its Regulatory consulting advisors.

Read more...

A World leading company in the discovery and development of fully-human antibody therapeutics today signed up with Aagami to finding them the licensing partner for their lead molecules as well as anti body discovery technologies for a wide range of diseases, including cancer.

Read more...